Electrophysiological characterization of a schistosome transient receptor potential channel activated by praziquantel

Int J Parasitol. 2023 Jul;53(8):415-425. doi: 10.1016/j.ijpara.2022.11.005. Epub 2023 Jan 4.

Abstract

Ion channels have proved to be productive targets for anthelmintic chemotherapy. One example is the recent discovery of a parasitic flatworm ion channel targeted by praziquantel (PZQ), the main clinical therapy used for treatment of schistosomiasis. The ion channel activated by PZQ - a transient receptor potential ion channel of the melastatin subfamily, named TRPMPZQ - is a Ca2+-permeable ion channel expressed in all parasitic flatworms that are PZQ-sensitive. However, little is currently known about the electrophysiological properties of this target that mediates the deleterious action of PZQ on many trematodes and cestodes. Here, we provide a detailed biophysical characterization of the properties of Schistosoma mansoni TRPMPZQ channel (Sm.TRPMPZQ) in response to PZQ. Single channel electrophysiological analysis demonstrated that Sm.TRPMPZQ when activated by PZQ is a non-selective, large conductance, voltage-insensitive cation channel that displays distinct properties from human TRPM paralogs. Sm.TRPMPZQ is Ca2+-permeable but does not require Ca2+ for channel gating in response to PZQ. TRPMPZQ from Schistosoma japonicum (Sj.TRPMPZQ) and Schistosoma haematobium (Sh.TRPMPZQ) displayed similar characteristics. Profiling Sm.TRPMPZQ responsiveness to PZQ has established a biophysical signature for this channel that will aid future investigation of endogenous TRPMPZQ activity, as well as analyses of endogenous and exogenous regulators of this novel, druggable antiparasitic target.

Keywords: Anthelmintic; Electrophysiology; Flatworm; Invertebrate; Ion channel; Parasite.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Anthelmintics* / pharmacology
  • Anthelmintics* / therapeutic use
  • Humans
  • Praziquantel / pharmacology
  • Praziquantel / therapeutic use
  • Schistosoma mansoni
  • Schistosomiasis mansoni* / drug therapy
  • TRPM Cation Channels* / genetics
  • Transient Receptor Potential Channels* / therapeutic use

Substances

  • Praziquantel
  • Transient Receptor Potential Channels
  • TRPM Cation Channels
  • Anthelmintics